BrightSpring Health Services, Inc. (BTSG)
NASDAQ: BTSG · Real-Time Price · USD
33.14
+0.54 (1.66%)
At close: Nov 7, 2025, 4:00 PM EST
33.60
+0.46 (1.39%)
Pre-market: Nov 10, 2025, 7:08 AM EST
BTSG Stock Forecast
Stock Price Forecast
The 7 analysts that cover BTSG stock have a consensus rating of "Strong Buy" and an average price target of $34, which forecasts a 2.60% increase in the stock price over the next year. The lowest target is $27 and the highest is $42.
Price Target: $34 (+2.60%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BTSG stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 3 | 3 | 3 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 8 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Maintains $30 → $41 | Strong Buy | Maintains | $30 → $41 | +23.72% | Oct 29, 2025 |
| UBS | UBS | Strong Buy Maintains $35 → $42 | Strong Buy | Maintains | $35 → $42 | +26.74% | Oct 29, 2025 |
| Mizuho | Mizuho | Buy Maintains $26 → $32 | Buy | Maintains | $26 → $32 | -3.44% | Oct 17, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $25 → $32 | Buy | Maintains | $25 → $32 | -3.44% | Oct 14, 2025 |
| UBS | UBS | Strong Buy Maintains $31 → $35 | Strong Buy | Maintains | $31 → $35 | +5.61% | Oct 13, 2025 |
Financial Forecast
Revenue This Year
12.94B
from 11.27B
Increased by 14.81%
Revenue Next Year
14.70B
from 12.94B
Increased by 13.68%
EPS This Year
1.02
from -0.09
EPS Next Year
1.32
from 1.02
Increased by 29.05%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 13.6B | 16.0B | |||
| Avg | 12.9B | 14.7B | |||
| Low | 12.2B | 13.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 20.3% | 23.5% | |||
| Avg | 14.8% | 13.7% | |||
| Low | 8.0% | 6.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.35 | 1.67 | |||
| Avg | 1.02 | 1.32 | |||
| Low | 0.74 | 1.02 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 63.7% | |||
| Avg | - | 29.0% | |||
| Low | - | -0.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.